TABLE 3.
Target | Specimen type | No. with resulta: |
Total no. | % (95% CI) forb: |
||||
---|---|---|---|---|---|---|---|---|
TP | FP | TN | FN | PPA | NPA | |||
blaCTX-M | Fresh | 45 | 0 | 657 | 1c | 703 | 97.8 (87–100) | 100.0 (99–100) |
Frozen | 28 | 0 | 733 | 1c | 762 | 96.6 (80–100) | 100.0 (99–100) | |
Simulated | 108 | 0 | 226 | 0 | 334 | 100.0 (96–100) | 100.0 (98–100) | |
Total | 181 | 0 | 1,616 | 2 | 1,799 | 98.9 (96–100) | 100.0 (99–100) | |
blaKPC | Fresh | 2 | 0 | 701 | 0 | 703 | 100.0 (20–100) | 100.0 (99–100) |
Frozen | 1 | 0 | 761 | 0 | 762 | 100.0 (5–100) | 100.0 (99–100) | |
Simulated | 50 | 0 | 284 | 0 | 334 | 100.0 (91–100) | 100.0 (98–100) | |
Total | 53 | 0 | 1,746 | 0 | 1,799 | 100.0 (92–100) | 100.0 (99–100) | |
blaNDM | Fresh | 1 | 0 | 702 | 0 | 703 | 100.0 (5–100) | 100.0 (99–100) |
Frozen | 0 | 0 | 762 | 0 | 762 | ND | 100.0 (99–100) | |
Simulated | 50 | 0 | 282 | 2d | 334 | 96.2 (86–100) | 100.0 (98–100) | |
Total | 51 | 0 | 1,746 | 2 | 1,799 | 96.2 (86–100) | 100.0 (99–100) | |
blaOXA | Fresh | 6 | 0 | 696 | 1e | 703 | 85.7 (42–99) | 100.0 (99–100) |
Frozen | 3 | 0 | 757 | 2e | 762 | 60.0 (17–93) | 100.0 (99–100) | |
Simulated | 57 | 1f | 275 | 1e | 334 | 98.3 (90–100) | 99.6 (98–100) | |
Total | 66 | 1 | 1,728 | 4 | 1,799 | 94.3 (85–98) | 99.9 (99–100) | |
blaVIM | Fresh | 0 | 0 | 703 | 0 | 703 | ND | 100.0 (99–100) |
Frozen | 0 | 0 | 762 | 0 | 762 | ND | 100.0 (99–100) | |
Simulated | 68 | 0 | 266 | 0 | 334 | 100.0 (93–100) | 100.0 (98–100) | |
Total | 68 | 0 | 1,731 | 0 | 1,799 | 100.0 (93–100) | 100.0 (99–100) | |
blaIMP | Fresh | 0 | 0 | 703 | 0 | 703 | ND | 100.0 (99–100) |
Frozen | 0 | 0 | 762 | 0 | 762 | ND | 100.0 (99–100) | |
Simulated | 47 | 0 | 287 | 0 | 334 | 100.0 (91–100) | 100.0 (98–100) | |
Total | 47 | 0 | 1,752 | 0 | 1,799 | 100.0 (91–100) | 100.0% (99–100) |
TP, true positive, FP, false positive, TN, true negative, FN, false negative.
PPA, positive percent agreement; NPA, negative percent agreement; 95% CI, 95% confidence interval; ND, not detected.
Confirmed to be blaCTX-M-1 by sequence analysis.
One of two confirmed to be blaNDM by sequence analysis. One was not available for discrepant analysis.
Confirmed to be blaOXA-23 by sequence analysis.
Negative for blaOXA by sequence analysis.